The Importance of Tau Phosphorylation for Neurodegenerative Diseases

Chapter 12: What does the Anthropocene hold for citizenship?

(2019) · edoc (University of Basel) · doi:10.1007/978-3 · Cited by 11,533

Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years

Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194

Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

SantaCruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., et al. (2005) · Science · doi:10.1126/science.1113694 · Cited by 2,014

Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models

Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821

Transmission and spreading of tauopathy in transgenic mouse brain

Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803

Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils

Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526

Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427

Propagation of Tau Misfolding from the Outside to the Inside of a Cell

Frost, B., Jacks, R. L., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808759200 · Cited by 1,252

Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration

Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118

Differential Regulation of Dynein and Kinesin Motor Proteins by Tau

Dixit, R., Ross, J. L., Goldman, Y. E., & Holzbaur, E. L. F. (2008) · Science · doi:10.1126/science.1152993 · Cited by 1,012

Electrochemical approaches for the detection of amyloid-β, tau, and α-synuclein

Hassan, Q., & Kerman, K. (2018) · Current Opinion in Electrochemistry · doi:10.1016/j.coelec.2018.12.009 · Cited by 21

Modulation of aggregation with an electric field; scientific roadmap for a potential non-invasive therapy against tauopathies

Pandey, G., Morla, S., Nemade, H. B., Kumar, S., & Ramakrishnan, V. (2019) · RSC Advances · doi:10.1039/c8ra09993f · Cited by 21

Neuronal Vulnerability of the Entorhinal Cortex to Tau Pathology in Alzheimer’s Disease

Zhang, S., Crossley, C. A., & Yuan, Q. (2024) · British Journal of Biomedical Science · doi:10.3389/bjbs.2024.13169 · Cited by 26

Tau R2 and R3 are essential regions for tau aggregation, seeding and propagation

Annadurai, N., Malina, L., Malohlava, J., Hajdúch, M., & Das, V. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.013 · Cited by 18

Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer’s Disease

Rathod, S., & Agrawal, Y. O. (2023) · Current Drug Research Reviews · doi:10.2174/2589977515666230502104021 · Cited by 18

Key Physicochemical and Biological Factors of the Phase Behavior of Tau

Nam, G., Lin, Y., Lim, M. H., & Lee, Y. (2020) · Chem · doi:10.1016/j.chempr.2020.09.012 · Cited by 20

New methods based on capillary electrophoresis for in vitro evaluation of protein tau phosphorylation by glycogen synthase kinase 3-β

Nehmé, H., Chantepie, S., Defert, J., Morin, P., Papy-García, D., & Nehmé, R. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8495-7 · Cited by 20

Examination of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation in former elite American football players

Miner, A. E., Groh, J. R., Tripodis, Y., Adler, C. H., Balcer, L. J., Bernick, C. B., Zetterberg, H., Blennow, K., Peskind, E. R., Ashton, N. J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14231 · Cited by 20

Tau acetylation at K280 regulates tau phosphorylation

Kim, M.-S., Mun, Y., Lee, S., Cho, W.-Y., Han, S.-H., Kim, D., & Yoon, S. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2081165 · Cited by 19

Imaging pathological tau in atypical parkinsonisms: A review

Mena, A. M., & Strafella, A. P. (2022) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2022.100155 · Cited by 20

Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases

Wu, Y.-F., Ma, B., Liu, C. Y., Li, D., & Sui, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810187 · Cited by 21

Contributive Role of Hyperglycemia and Hypoglycemia Towards the Development of Alzheimer’s Disease

Chakrabarty, R., Yousuf, S., & Singh, M. P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02846-y · Cited by 20

Targeted protein modification as a paradigm shift in drug discovery

Amirian, R., Azadi Badrbani, M., Izadi, Z., Samadian, H., Bahrami, G., Sarvari, S., Abdolmaleki, S., Nabavi, S. M., Derakhshankhah, H., & Jaymand, M. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115765 · Cited by 18

Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease

Seplovich, G., Bouchi, Y., Vaccari, J. P. D. R., Pareja, J. C. M., Reisner, A., Blackwell, L. S., Mechref, Y. S., Wang, K., Tyndall, J. A., Tharakan, B., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00107 · Cited by 21

Recent Preclinical Insights Into the Treatment of Chronic Traumatic Encephalopathy

Breen, P., & Krishnan, V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00616 · Cited by 19

Somatic Mutations and Alzheimer’s Disease

Downey, J., Lam, J. C. K., Li, V. O. K., & Gozes, I. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220643 · Cited by 18

Verbal memory formation across PET-based Braak stages of tau accumulation in Alzheimer’s disease

Arias, J. F., Therriault, J., Thomas, E. M., Lussier, F. Z., Bezgin, G., Tissot, C., Servaes, S., Mathotaarachchi, S. S., Schoemaker, D., Stevenson, J., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad146 · Cited by 17

Glioblastoma and its treatment are associated with extensive accelerated brain aging

Ainslie, A. P., Klaver, M., Voshart, D. C., Gerrits, E., den Dunnen, W. F. A., Eggen, B. J. L., Bergink, S., & Barazzuol, L. (2024) · Aging Cell · doi:10.1111/acel.14066 · Cited by 17

Korean red ginseng polysaccharide as a potential therapeutic agent targeting tau pathology in Alzheimer's disease

Kim, S., Shin, S. J., Nam, Y., Park, Y. H., Kim, B., Park, H. H., Kumar, V., Yoo, D., Lee, Y. Y., Hoe, H., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130516 · Cited by 18

Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects

Alyenbaawi, H., Allison, W. T., & Mok, S. (2020) · Biomolecules · doi:10.3390/biom10111487 · Cited by 20

Considerations for future tau-targeted therapeutics: can they deliver?

Noble, W. J., Jiménez-Sánchez, M., Perez‐Nievas, B. G., & Hanger, D. P. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1685977 · Cited by 16

Oral (−)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β

Hole, K. L., Staniaszek, L. E., Balan, G. M., Mason, J. M., Brown, J. T., & Williams, R. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.697319 · Cited by 16

Separation of Isomeric Tau Phosphopeptides from Alzheimer’s Disease Brain by Cyclic Ion Mobility Mass Spectrometry

Kováč, A., Majerová, P., Nytka, M., Cechová, M. Z., Bednář, P., Hájek, R., Cooper-Shepherd, D. A., Muck, A., & Lemr, K. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00289 · Cited by 18

Comparative assessment of regional tau distribution by Tau-PET and Post-mortem neuropathology in a representative set of Alzheimer’s & frontotemporal lobar degeneration patients

Gatto, R. G., Carlos, A. F., Reichard, R. R., Lowe, V. J., Whitwell, J. L., & Josephs, K. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284182 · Cited by 17

Untangling Tau: Molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies

Davidson, R., Krider, R. I., Borsellino, P., Noorda, K., Alhwayek, G., & Vida, T. A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110553 · Cited by 17

Identification of AS1842856 as a novel small‐molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis

He, D., Zhang, X., Su, J., Zhang, Q., Zhao, L., Wu, T., Hang, R., Jia, R., Lei, X., Hou, W., et al. (2024) · Aging Cell · doi:10.1111/acel.14336 · Cited by 16

Novel monoclonal antibodies targeting the microtubule-binding domain of human tau

Croft, C. L., Moore, B. D., Ran, Y., Chakrabarty, P., Levites, Y., Golde, T. E., & Giasson, B. I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195211 · Cited by 16

Drugs for Targeted Therapies of Alzheimer’s Disease

Tam, C., Wong, J. H., Ng, T. B., Tsui, S. K., & Zuo, T. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180430150940 · Cited by 15

Human Induced Pluripotent Stem Cell Models of Frontotemporal Dementia With Tau Pathology

Kühn, R., Mahajan, A., Canoll, P., & Hargus, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.766773 · Cited by 18

P301 L, an FTDP-17 Mutant, Exhibits Enhanced Glycation in vitro

Sonawane, S. K., & Chinnathambi, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191348 · Cited by 15

Neuroprotective repositioning and anti-tau effect of carvedilol on rotenone induced neurotoxicity in rats: Insights from an insilico& in vivo anti-Parkinson's disease study

Kamal, R. E., Menze, E. T., Albohy, A., Ahmed, H. I., & Azab, S. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175204 · Cited by 16

Role of the Cysteine in R3 Tau Peptide in Copper Binding and Reactivity

Bacchella, C., Gentili, S., Mozzi, S. I., Monzani, E., Casella, L., Tegoni, M., & Dell’Acqua, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810726 · Cited by 16

Tau trajectory in Alzheimer’s disease: Evidence from the connectome-based computational models

Bitra, V. R., Challa, S. R., Adiukwu, P. C., & Rapaka, D. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110777 · Cited by 15

Imaging tau pathology in Parkinsonisms

Coakeley, S., & Strafella, A. P. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0023-3 · Cited by 15

Impact of Phosphorylation and Pseudophosphorylation on the Early Stages of Aggregation of the Microtubule-Associated Protein Tau

Prokopovich, D., Whittaker, J. W., Muthee, M. M., Ahmed, A., & Larini, L. (2017) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b00194 · Cited by 15

Neuroinflammation and nutrition in Alzheimer’s disease

Park, H., Ni, M., & Le, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1622571 · Cited by 17

From bite to brain: Neuro‐immune interactions in food allergy

Houghton, V., Eiwegger, T., Florsheim, E. B., Knibb, R. C., Thuret, S., & Santos, A. F. (2024) · Allergy · doi:10.1111/all.16366 · Cited by 16

α-Synuclein and tau, two targets for dementia

Silva, M., Caro, V., Guzmán, C., Perry, G. L., Areche, C., & Cornejo, A. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819483-6.00001-1 · Cited by 15

Amyloid Beta and Tau: from Physiology to Pathology in Alzheimer’s Disease

Khaledi, S., ایران, گ. ع. ز. د. ع. د. ک. س., Ahmadi, S., & ایران, گ. ع. ز. د. ع. د. ک. س. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.4.67 · Cited by 14

PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer’s disease

Poirier, A., Picard, C., Labonté, A., Aubry, I., Auld, D. S., Zetterberg, H., Blennow, K., Poirier, J., Breitner, J. C. S., Poirier, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65104-2 · Cited by 14

Proteostasis as a fundamental principle of Tau immunotherapy

Cruz, E., Nisbet, R. M., Padmanabhan, P., Waardenberg, A. J., Graham, M. E., Nkajja, G., Tapaswi, S., Connor, B. J., Robinson, P., & Götz, J. (2024) · Brain · doi:10.1093/brain/awae254 · Cited by 15

Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin

Barbolina, M. V. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105585 · Cited by 13

Bushen-Huatan-Yizhi formula reduces spatial learning and memory challenges through inhibition of the GSK-3β/CREB pathway in AD-like model rats

Yang, S., Shi, H., Zeng, P. H., Xia, J., Wang, P., & Li, L. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153624 · Cited by 13

Exendin-4 Improves Cognitive Function of Diabetic Mice via Increasing Brain Insulin Synthesis

Peng, X., Shi, X., Huang, J., Zhang, S., Yan, Y., Ma, D., Xu, W., Xu, W., Dong, K., Tao, J., et al. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210929150004 · Cited by 13

Tau Protein and Zebrafish Models for Tau-Induced Neurodegeneration

Ding, Y., Lei, L., Lai, C., & Tang, Z. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180917 · Cited by 13

The effect of lipid composition on the dynamics of tau fibrils

Chowdhury, U. D., Paul, A., & Bhargava, B. L. (2022) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26401 · Cited by 12

Tau-S214 Phosphorylation Inhibits Fyn Kinase Interaction and Increases the Decay Time of NMDAR-mediated Current

Jos, S., Poulose, R., Kambaru, A., Gogoi, H., Nanjaiah, N. D., Padmanabhan, B., Mehta, B., & Padavattan, S. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168445 · Cited by 12

Extracellular vesicle-packed microRNAs profiling in Alzheimer’s disease: The molecular intermediary between pathology and diagnosis

Arif, S., Qazi, T. J., Quan, Z., Ni, J., Li, Z., Qiu, Y., & Qing, H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102614 · Cited by 13

Excessive Alcohol Use as a Risk Factor for Alzheimer’s Disease: Epidemiological and Preclinical Evidence

Anton, P. E., Maphis, N. M., Linsenbardt, D. N., & Coleman, L. G. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-81908-7_10 · Cited by 12

Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease

Okafor, M., Faller, P., & Vitale, N. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00504-6 · Cited by 16

Endoplasmic Reticulum Stress in Tauopathies: Contrasting Human Brain Pathology with Cellular and Animal Models

Bocai, N. I., Marcora, M. S., Belfiori-Carrasco, L. F., Morelli, L., & Castaño, E. M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181021 · Cited by 12

Disordered Expression of shaggy, the Drosophila Gene Encoding a Serine-Threonine Protein Kinase GSK3, Affects the Lifespan in a Transcript-, Stage-, and Tissue-Specific Manner

Trostnikov, M. V., Roshina, N. V., Boldyrev, S. V., Veselkina, E. R., Zhuikov, A. A., Krementsova, A. V., & PASYUKOVA, E. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092200 · Cited by 12

Retinoic acid regulates the ubiquitin–proteasome system in a middle cerebral artery occlusion animal model

Kang, J.-B., Shah, M.-A., Park, D.-J., & Koh, P. (2022) · Laboratory Animal Research · doi:10.1186/s42826-022-00123-6 · Cited by 13

RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease

Medd, M. M., Yon, J. E., & Dong, H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47020124 · Cited by 11

Therapeutic Potential of Capsaicin in Various Neurodegenerative Diseases with Special Focus on Nrf2 Signaling

Varshney, V., Kumar, A., Parashar, V., Kumar, A., Goyal, A., & Garabadu, D. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010277933231122111244 · Cited by 12

Targeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer’s Disease

Velez, J. I., Lopera, F. J., Creagh, P. K., Piñeros-Hernández, L. B., Das, D., Cervantes-Henríquez, M. L., Acosta-López, J. E., Isaza-Ruget, M. A., Espinosa, L. G., Easteal, S., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1298-z · Cited by 12

4R-Tau seeding activity unravels molecular subtypes in patients with Progressive Supranuclear PalsyPreprint

Martínez-Valbuena, I., Lee, S., Santamaría, E., Fernández‐Irigoyen, J., Forrest, S. L., Li, J., Tanaka, H., Couto, B., Reyes, N. G. D., Qamar, S. H., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.28.559953 · Cited by 11

Analysis of early effects of human APOE isoforms on Alzheimer’s disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE

Yesiltepe, M., Yin, T., Tambini, M., Bao, H., Pan, M., d’Abramo, C., Giliberto, L., Han, X., & D’Adamio, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01832-2 · Cited by 10

From Acute Injury to Chronic Neurodegeneration: Molecular Mechanisms Linking Secondary Brain Injury to Long-Term Pathology

Kaniuk, J. K., Kumar, D., Mazurek, C. Y., Khavari, S., Sollenberger, C. H., Ahuja, A., Mossner, J. M., & Ahuja, C. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157191 · Cited by 11

The Association between Tau Protein Level in Cerebrospinal Fluid and Cognitive Status: A Large-Scale Analysis of GAAIN Database

Eckhoff, K., Morris, R., Zuluaga, V., Polsky, R., & Cheng, F. (2021) · Brain Sciences · doi:10.3390/brainsci11070861 · Cited by 10

Plasma neurofilament light-chain and phosphorylated tau as biomarkers of disease severity in Huntington's disease: Korean cohort data

Hwang, Y. S., Oh, E., Kim, M., Lee, C. Y., Kim, H. S., Chung, S. J., Sung, Y. H., Yoon, W. T., Cho, J. H., Lee, J., et al. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120744 · Cited by 10

Huang‐Pu‐Tong‐Qiao Formula Ameliorates Tau Phosphorylation by Inhibiting the CaM‐CaMKIV Pathway

Ye, S., Cai, B., Zhou, P., Guo-Quan, W., Gao, H., Hua, R., You, L., Yao, Y., Wang, Y., & Shen, G.-M. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8956071 · Cited by 10

Activity-dependent release of phosphorylated human tau from Drosophila neurons in primary culture

Ismael, S., Sindi, G., Colvin, R. A., & Lee, D. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101108 · Cited by 12

Role of Oxygen Radicals in Alzheimer’s Disease: Focus on Tau Protein

Atlante, A., Valenti, D., Latina, V., & Amadoro, G. (2021) · Oxygen · doi:10.3390/oxygen1020010 · Cited by 11

Benzothiazole Substitution Analogs of Rhodacyanine Hsp70 Inhibitors Modulate Tau Accumulation

Hill, S. E., Beaulieu‐Abdelahad, D., Lemus, A., Webster, J. M., Ospina, S. R., Darling, A. L., Martin, M. D., Patel, S., Bridenstine, L., Swonger, R., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00919 · Cited by 9

Roles of Nucleic Acids in Protein Folding, Aggregation, and Disease

Litberg, T. J., & Horowitz, S. A. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.3c00695 · Cited by 10

A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer’s Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants

Tsamou, M., Pistollato, F., & Roggen, E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201418 · Cited by 9

Current trends and updates in the treatment of Alzheimer's disease

Parikh, N. H., Parikh, P. K., Rao, H. J., Shah, K., Dave, B. P., & Prajapati, B. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00014-5 · Cited by 9

Derailed Intraneuronal Signalling Drives Pathogenesis in Sporadic and Familial Alzheimer’s Disease

Dooren, T. V., Princen, K., Witte, K. D., & Griffioen, G. (2014) · BioMed Research International · doi:10.1155/2014/167024 · Cited by 9

New advances in tau imaging in parkinsonism

Valli, M., & Strafella, A. P. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1396446 · Cited by 9

Cre-inducible Adeno Associated Virus-mediated Expression of P301L Mutant Tau Causes Motor Deficits and Neuronal Degeneration in the Substantia Nigra

You, Y., Botros, M. B., Enoo, A. A. V., Bockmiller, A., Herron, S., Delpech, J.-C., & Ikezu, T. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.001 · Cited by 9

Aberrant accumulation of age- and disease-associated factors following neural probe implantation in a mouse model of Alzheimer’s disease

Wellman, S. M., Coyne, O., Douglas, M. M., & Kozai, T. D. Y. (2023) · Journal of Neural Engineering · doi:10.1088/1741-2552/aceca5 · Cited by 8

Molecular Dynamics Simulation of Tau Peptides for the Investigation of Conformational Changes Induced by Specific Phosphorylation Patterns

Gandhi, N. S., Kukić, P., Lippens, G. M., & Mancera, R. L. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_3 · Cited by 9

Advances in the study of protein folding and endoplasmic reticulum-associated degradation in mammal cells

Cao, H., Zhou, X., Xu, B., Hu, H., Guo, J., Ma, Y., Wang, M., Li, N., & Zou, J. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300403 · Cited by 9

Synthesis and preliminary evaluation of novel PET probes for GSK-3 imaging

Gundam, S. R., Bansal, A., Kethamreddy, M., Ghatamaneni, S., Lowe, V. J., Murray, M. E., & Pandey, M. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-65943-z · Cited by 8

Distinct factors drive the progression of tau pathology in Alzheimer’s disease

Luo, Y., Yu, H., & Ye, K. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.04.001 · Cited by 9

Tau pathology reprograms glucose metabolism to support cortical hyperexcitability, excitatory/inhibitory imbalance, and sleep loss

Irmen, R. E., Turner, S. M., Snipes, J. A., Schloss, K. H., Wang, X., Williams, H. C., Velmurugan, G. V., Hunt, J. B., Li, J., Sullivan, P. G., et al. (2026) · npj Dementia · doi:10.1038/s44400-025-00054-8 · Cited by 11

Generation and characterization of a tractable C. elegans model of tauopathy

Russell, J. C., Lei, H., Chaliparambil, R. K., Fish, S., Markiewicz, S. M., Lee, T.-I., Noori, A., & Kaeberlein, M. R. (2021) · GeroScience · doi:10.1007/s11357-021-00436-9 · Cited by 11

The 28-day repeated arsenic exposure increases tau phosphorylation in the rat brain

Wisessaowapak, C., Worasuttayangkurn, L., Maliphol, K., Nakareangrit, W., Cholpraipimolrat, W., Nookabkaew, S., Watcharasit, P., & Satayavivad, J. (2022) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2022.103974 · Cited by 8

Arabidopsis hypocotyl growth in darkness requires the phosphorylation of a microtubule‐associated protein

Arico, D. S., Wengier, D. L., Burachik, N. B., & Mazzella, M. A. (2024) · The Plant Journal · doi:10.1111/tpj.16711 · Cited by 8

Impact of Phosphorylation and O-GlcNAcylation on the Binding Affinity of R4 Tau Peptide to Microtubule and Its Conformational Preference upon Dissociation

Dasari, S., & Kalyaanamoorthy, S. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c02109 · Cited by 8

Impact of chronic hyperglycemia on Small Heat Shock Proteins in diabetic rat brain

Reddy, V., Pandarinath, S., Archana, M., & Reddy, G. B. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108816 · Cited by 8

Dual action of exosomes derived from in vitro Aβ toxicity model: The role of age for pathological response

Beker, M., GÜnay, N., Johnson, B. S., Cakmak, R. K., Ercin, N., Altıntaş, M. Ö., Altunay, S., Beker, M. Ç., Sari, D., & Kılıç, Ü. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2022.104874 · Cited by 8

Gliosis, misfolded protein aggregation, and neuronal loss in a guinea pig model of pulmonary tuberculosis

Latham, A. S., Geer, C. E., Ackart, D. F., Anderson, I. K., Vittoria, K. M., Podell, B. K., Basaraba, R. J., & Moreno, J. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1157652 · Cited by 9

Dynamic neuroinflammatory profiles predict Alzheimer’s disease pathology in microglia-containing cerebral organoidsPreprint

Kuhn, M. K., Kang, R. Y., Kim, C., Tagay, Y., Morris, N., Tabdanov, E. D., Elcheva, I. A., & Proctor, E. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567220 · Cited by 9

Untangling the role of tau in sex hormone responsive cancers: lessons learnt from Alzheimer's disease

Barker, R. M., Chambers, A., Kehoe, P. G., Rowe, E., & Perks, C. M. (2024) · Clinical Science · doi:10.1042/cs20230317 · Cited by 9

Phosphorylated-tau associates with HSV-1 chromatin and correlates with nuclear speckles decondensation in low-density host chromatin regions

D’Aiuto, L., Caldwell, J. K., Edwards, T. G., Zhou, C., McDonald, M. L., Maio, R. D., Joel, W., Hyde, V. R., Wallace, C. T., Watkins, S. C., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106804 · Cited by 7

Phospho-proteome profiling in human neurons reveals targets of TBK1 in ALS/FTD-associated autophagy networks

Smeyers, J., Osés-Prieto, J. A., Yadanar, L., Wang, M., Iadarola, M., Lu, S. H.-A., Wang, K. S., Watanabe, T. H., Debnath, J., Burlingame, A. L., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116494 · Cited by 8

Tau-aggregation inhibition: promising role of nanoencapsulated dietary molecules in the management of Alzheimer’s disease

Nagaraju, P. G., Ashwini, S., & G., P. P. C. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2092446 · Cited by 7

Liquid–liquid phase separation in neurodegenerative diseases

Haider, R., Boyko, S., & Surewicz, W. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823967-4.00018-x · Cited by 7

Altered amyloid precursor protein, tau‐regulatory proteins, neuronal numbers and behaviour, but no tau pathology, synaptic and inflammatory changes or memory deficits, at 1 month following repetitive mild traumatic brain injury

Juan, S. M. A., Daglas, M., & Adlard, P. A. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15752 · Cited by 8

Site-Specific C-Terminal Fluorescent Labeling of Tau Protein

Bryan, L. C., Awasthi, S., Li, Y., Nirmalraj, P. N., Balog, S., Yang, J., & Mayer, M. (2022) · ACS Omega · doi:10.1021/acsomega.2c06139 · Cited by 7

Neuronal Genes and Developmental Neuronal Pathways in Drosophila Life Span Control

PASYUKOVA, E. G., Symonenko, A. V., Roshina, N. V., Trostnikov, M. V., Veselkina, E. R., & Rybina, O. Y. (2015) · Healthy ageing and longevity · doi:10.1007/978-3-319-18326-8_1 · Cited by 8

An Overview of Transgenic Mouse Models for the Study of Alzheimer’s Disease

Lopes, P. A., Pádua, M. S., & Guil‐Guerrero, J. L. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2010002 · Cited by 9

Site-specific molecular glues for the 14-3-3/Tau pS214 protein–protein interaction via reversible covalent imine tethering

Oberheide, A., van den Oetelaar, M. C. M., Scheele, J. J., Borggräfe, J., Engelen, S. F. H., Sattler, M., Ottmann, C., Cossar, P. J., & Brunsveld, L. (2025) · RSC Medicinal Chemistry · doi:10.1039/d4md00833b · Cited by 6

Diagnostic Role of Tau Proteins in Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis

Thapa, S., Bhattarai, A., Shah, S., Chand, S., Bagherieh, S., Mirmosayyeb, O., & Mishra, S. K. (2023) · Acta Neurologica Scandinavica · doi:10.1155/2023/2791622 · Cited by 6

Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer’s disease

Adnan, M., DasGupta, D., Anwar, S., Shamsi, A., Siddiqui, A. J., Snoussi, M., Bardakçi, F., Patel, M. B., & Hassan, M. I. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1276179 · Cited by 6

Human tauopathy strains defined by phosphorylation in R1-R2 repeat domains of tau

Smith, E. D., Vo, Q., Giasson, B. I., Borchelt, D., Prokop, S., & Chakrabarty, P. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01664-0 · Cited by 6

Severe neurodegeneration in brains of transgenic rats producing human tau prions

Ayers, J. I., Lopez, T. P., Steele, I. T., Oehler, A., Roman-Albarran, R., Cleveland, E., Chong, A., Carlson, G. A., Condello, C., & Prusiner, S. B. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02771-5 · Cited by 7

The LPA-CDK5-tau pathway mediates neuronal injury in an in vitro model of ischemia-reperfusion insult

Wang, Y., Zhang, J., Huang, L., Mo, Y., Wang, C., Li, Y., Zhang, Y., & Zhang, Z. (2022) · BMC Neurology · doi:10.1186/s12883-022-02694-2 · Cited by 6

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies

Rawat, P., Sehar, U., Bisht, J., Selman, A., Culberson, J., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112841 · Cited by 509

Tau phosphorylation: the therapeutic challenge for neurodegenerative disease

Hanger, D. P., Anderton, B. H., & Noble, W. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.01.003 · Cited by 965

The Role of Tau Phosphorylation in the Pathogenesis of Alzheimers Disease

Mi, K., & Johnson, G. V. W. (2006) · Current Alzheimer Research · doi:10.2174/156720506779025279 · Cited by 166

Further understanding of tau phosphorylation: implications for therapy

Medina, M., & Avila, J. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1000864 · Cited by 41

Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders

Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174